Cyclooxygenase-2 (Coxoxy-2) inhibitors and inducible nitric oxide synthase (iNOS) inhibitors are targets for the treatment of pain, depression, and fatigue (Von Ah et al., 2008). The gene discussed is NOS2; the disease is depressive symptom measurement.